CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woessner, R. D.
Right arrow Articles by Drake, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woessner, R. D.
Right arrow Articles by Drake, F. H.

Cell Growth & Differentiation, Vol 2, Issue 4 209-214, Copyright © 1991 by American Association of Cancer Research


ARTICLES

Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells

RD Woessner, MR Mattern, CK Mirabelli, RK Johnson and FH Drake
Research and Development, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.

The cellular content of 170kD and 180kD topoisomerase II was studied as a function of the proliferation state and cell cycle position in NIH-3T3 cells. When the cells were synchronized by serum starvation and then stimulated to enter the cell cycle by addition of fresh growth medium, the amount of 170kD topoisomerase II present was undetectable until the cells reached late S phase, peaked in G2-M phase cells, and decreased as the cells completed mitosis. The amount of 180kD topoisomerase II was constant once the cells entered the cell cycle. When exponentially growing cells were induced to enter G0 by serum starvation, the amount of 170kD topoisomerase II decreased in parallel with the loss of cells from the S and G2-M phases of the cell cycle and was undetectable once all of the cells reached G0. In contrast, the 180kD enzyme was still present after all of the cells had entered G0. The tightness of association of the two enzymes with chromatin was measured by determining the concentration of salt required to extract them from isolated nuclei. The 180kD enzyme required a higher concentration of NaCl for extraction than did the 170kD enzyme. The different patterns of expression of the two forms of topoisomerase II suggest that they perform different functions in cells.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. Kanagasabai, L. Serdar, S. Karmahapatra, C. A. Kientz, J. Ellis, M. K. Ritke, T. S. Elton, and J. C. Yalowich
Alternative RNA Processing of Topoisomerase II{alpha} in Etoposide-Resistant Human Leukemia K562 Cells: Intron Retention Results in a Novel C-Terminal Truncated 90-kDa Isoform
J. Pharmacol. Exp. Ther., January 1, 2017; 360(1): 152 - 163.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R.-K. Lin, C.-W. Ho, L. F. Liu, and Y. L. Lyu
Topoisomerase II{beta} Deficiency Enhances Camptothecin-induced Apoptosis
J. Biol. Chem., March 8, 2013; 288(10): 7182 - 7192.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. K. Tiwari, L. Burger, V. Nikoletopoulou, R. Deogracias, S. Thakurela, C. Wirbelauer, J. Kaut, R. Terranova, L. Hoerner, C. Mielke, et al.
Target genes of Topoisomerase II{beta} regulate neuronal survival and are defined by their chromatin state
PNAS, April 17, 2012; 109(16): E934 - E943.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R.-K. Lin, N. Zhou, Y. L. Lyu, Y.-C. Tsai, C.-H. Lu, J. Kerrigan, Y.-t. Chen, Z. Guan, T.-S. Hsieh, and L. F. Liu
Dietary Isothiocyanate-induced Apoptosis via Thiol Modification of DNA Topoisomerase II{alpha}
J. Biol. Chem., September 23, 2011; 286(38): 33591 - 33600.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Srikantan, K. Abdelmohsen, E. K. Lee, K. Tominaga, S. S. Subaran, Y. Kuwano, R. Kulshrestha, R. Panchakshari, H. H. Kim, X. Yang, et al.
Translational Control of TOP2A Influences Doxorubicin Efficacy
Mol. Cell. Biol., September 15, 2011; 31(18): 3790 - 3801.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Dovey, E. E. Patton, T. Bowman, T. North, W. Goessling, Y. Zhou, and L. I. Zon
Topoisomerase II{alpha} Is Required for Embryonic Development and Liver Regeneration in Zebrafish
Mol. Cell. Biol., July 1, 2009; 29(13): 3746 - 3753.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Zeng, D. Sachdev, H. Zhang, M. Gaillard-Kelly, and D. Yee
Sequencing of Type I Insulin-Like Growth Factor Receptor Inhibition Affects Chemotherapy Response In vitro and In vivo
Clin. Cancer Res., April 15, 2009; 15(8): 2840 - 2849.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
E. Toyoda, S. Kagaya, I. G. Cowell, A. Kurosawa, K. Kamoshita, K. Nishikawa, S. Iiizumi, H. Koyama, C. A. Austin, and N. Adachi
NK314, a Topoisomerase II Inhibitor That Specifically Targets the {alpha} Isoform
J. Biol. Chem., August 29, 2008; 283(35): 23711 - 23720.
[Abstract] [Full Text] [PDF]


Home page
Biochem. J.Home page
M. Iida, M. Matsuda, and H. Komatani
Plk3 phosphorylates topoisomerase II{alpha} at Thr1342, a site that is not recognized by Plk1
Biochem. J., April 1, 2008; 411(1): 27 - 32.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. A. Doussis-Anagnostopoulou, T. P. Vassilakopoulos, I. Thymara, P. Korkolopoulou, M. K. Angelopoulou, M. P. Siakantaris, S. I. Kokoris, E. M. Dimitriadou, C. Kalpadakis, M. Matzouranis, et al.
Topoisomerase II{alpha} Expression as an Independent Prognostic Factor in Hodgkin's Lymphoma
Clin. Cancer Res., March 15, 2008; 14(6): 1759 - 1766.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. M. Spence, H. H. Phua, W. Mills, A. J. Carpenter, A. C. G. Porter, and C. J. Farr
Depletion of topoisomerase II{alpha} leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads
J. Cell Sci., November 15, 2007; 120(22): 3952 - 3964.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C.-Y. Xie, H. Zhu, L.-P. Lin, Z.-H. Miao, M.-Y. Geng, Y.-J. Cai, Y. Chen, H.-J. Zhao, H.-B. Luo, X.-W. Zhang, et al.
MFTZ-1, an actinomycetes subspecies derived antitumor macrolide, functions as a novel topoisomerase II poison
Mol. Cancer Ther., November 1, 2007; 6(11): 3059 - 3070.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Yoshida, T. Yamaguchi, H. Shinagawa, N. Taira, K. I. Nakayama, and Y. Miki
Protein Kinase C {delta} Activates Topoisomerase II{alpha} To Induce Apoptotic Cell Death in Response to DNA Damage
Mol. Cell. Biol., May 1, 2006; 26(9): 3414 - 3431.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. C. Marchion, E. Bicaku, J. G. Turner, A. I. Daud, D. M. Sullivan, and P. N. Munster
Synergistic Interaction between Histone Deacetylase and Topoisomerase II Inhibitors Is Mediated through Topoisomerase II{beta}
Clin. Cancer Res., December 1, 2005; 11(23): 8467 - 8475.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. K. McClendon, A. C. Rodriguez, and N. Osheroff
Human Topoisomerase II{alpha} Rapidly Relaxes Positively Supercoiled DNA: IMPLICATIONS FOR ENZYME ACTION AHEAD OF REPLICATION FORKS
J. Biol. Chem., November 25, 2005; 280(47): 39337 - 39345.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Skladanowski, M.-G. Come, M. Sabisz, A. E. Escargueil, and A. K. Larsen
Down-Regulation of DNA Topoisomerase II{alpha} Leads to Prolonged Cell Cycle Transit in G2 and Early M Phases and Increased Survival to Microtubule-Interacting Agents
Mol. Pharmacol., September 1, 2005; 68(3): 625 - 634.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Yamauchi, K.-i. Katayama, M. Ueno, K. Uetsuka, H. Nakayama, and K. Doi
Involvement of p53 in 1-{beta}-D-Arabinofuranosylcytosine-Induced Trophoblastic Cell Apoptosis and Impaired Proliferation in Rat Placenta
Biol Reprod, June 1, 2004; 70(6): 1762 - 1767.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Sakaguchi and A. Kikuchi
Functional compatibility between isoform {alpha} and {beta} of type II DNA topoisomerase
J. Cell Sci., March 1, 2004; 117(7): 1047 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. P. Braybrooke, N. C. Levitt, S. Joel, T. Davis, S. Madhusudan, H. Turley, S. Wilner, A. L. Harris, and D. C. Talbot
Pharmacokinetic Study of Cisplatin and Infusional Etoposide Phosphate in Advanced Breast Cancer with Correlation of Response to Topoisomerase II{alpha} Expression
Clin. Cancer Res., October 15, 2003; 9(13): 4682 - 4688.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. Adachi, H. Suzuki, S. Iiizumi, and H. Koyama
Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193: IMPLICATIONS FOR THE REPAIR OF TOPOISOMERASE II-MEDIATED DNA DAMAGE
J. Biol. Chem., September 19, 2003; 278(38): 35897 - 35902.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Pors, Z. Paniwnyk, P. Teesdale-Spittle, J. A. Plumb, E. Willmore, C. A. Austin, and L. H. Patterson
Alchemix: A Novel Alkylating Anthraquinone with Potent Activity against Anthracycline- and Cisplatin-resistant Ovarian Cancer
Mol. Cancer Ther., July 1, 2003; 2(7): 607 - 610.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Uzbekov, E. Timirbulatova, E. Watrin, F. Cubizolles, D. Ogereau, P. Gulak, V. Legagneux, V. Ju. Polyakov, K. Le Guellec, and I. Kireev
Nucleolar association of pEg7 and XCAP-E, two members of Xenopus laevis condensin complex in interphase cells
J. Cell Sci., May 1, 2003; 116(9): 1667 - 1678.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Xiao, Y. Mao, S. D. Desai, N. Zhou, C.-Y. Ting, J. Hwang, and L. F. Liu
The topoisomerase II{beta} circular clamp arrests transcription and signals a 26S proteasome pathway
PNAS, March 18, 2003; 100(6): 3239 - 3244.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. A. Joshi, Z. Wu, R. F. Reed, and D. P. Suttle
Nuclear Factor-Y Binding to the Topoisomerase IIalpha Promoter Is Inhibited by Both the p53 Tumor Suppressor and Anticancer Drugs
Mol. Pharmacol., February 1, 2003; 63(2): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
E. J. Mensah-Osman, A. M. Al-Katib, H.-Y. Wu, N. I. Osman, and R. M. Mohammad
2-[4-(7-Chloro-2-quinoxalinyloxy)phenoxy]-propionic Acid (XK469), an Inhibitor of Topoisomerase (Topo) II{beta}, Up-Regulates Topo II{alpha} and Enhances Topo II{alpha}-mediated Cytotoxicity
Mol. Cancer Ther., December 1, 2002; 1(14): 1321 - 1326.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. B. Peters and J. M. Brown
Tirapazamine: A Hypoxia-activated Topoisomerase II Poison
Cancer Res., September 15, 2002; 62(18): 5248 - 5253.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
A. P. Null, J. Hudson, and G. J. Gorbsky
Both {alpha} and {beta} Isoforms of Mammalian DNA Topoisomerase II Associate with Chromosomes in Mitosis
Cell Growth Differ., July 1, 2002; 13(7): 325 - 333.
[Abstract] [Full Text]


Home page
Molecular Cancer TherapeuticsHome page
E. U. Kurz, S. E. Wilson, K. B. Leader, B. P. Sampey, W. P. Allan, J. C. Yalowich, and D. J. Kroll
The Histone Deacetylase Inhibitor Sodium Butyrate Induces DNA Topoisomerase II{alpha} Expression and Confers Hypersensitivity to Etoposide in Human Leukemic Cell Lines
Mol. Cancer Ther., December 1, 2001; 1(2): 121 - 131.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Y. Mao, S. D. Desai, C.-Y. Ting, J. Hwang, and L. F. Liu
26 S Proteasome-mediated Degradation of Topoisomerase II Cleavable Complexes
J. Biol. Chem., November 2, 2001; 276(44): 40652 - 40658.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. Tsutsui, K. Tsutsui, K. Sano, A. Kikuchi, and A. Tokunaga
Involvement of DNA Topoisomerase II{beta} in Neuronal Differentiation
J. Biol. Chem., February 23, 2001; 276(8): 5769 - 5778.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. E. Morgan and W. T. Beck
Role of an Inverted CCAAT Element in Human Topoisomerase II{alpha} Gene Expression in ICRF-187-Sensitive and -Resistant CEM Leukemic Cells
Mol. Pharmacol., February 1, 2001; 59(2): 203 - 211.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A J Lodge, A G Hall, M M Reid, G G McIntosh, M Steward, J J Anderson, C H W Horne, and B Angus
Topoisomerase II{{alpha}} and II{beta} expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome
J. Clin. Pathol., January 1, 2001; 54(1): 31 - 36.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. W. Stacey, M. Hitomi, and G. Chen
Influence of Cell Cycle and Oncogene Activity upon Topoisomerase IIalpha Expression and Drug Toxicity
Mol. Cell. Biol., December 15, 2000; 20(24): 9127 - 9137.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
H. U. Barthelmes, P. Grue, S. Feineis, T. Straub, and F. Boege
Active DNA Topoisomerase II{alpha} Is a Component of the Salt-stable Centrosome Core
J. Biol. Chem., December 8, 2000; 275(49): 38823 - 38830.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. J. Satterwhite, R. L. White, N. Matsunami, and K. L. Neufeld
Inhibition of Topoisomerase II{{alpha}} Expression by Transforming Growth Factor-{beta}1 Is Abrogated by the Papillomavirus E7 Protein
Cancer Res., December 1, 2000; 60(24): 6989 - 6994.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Y. Mao, S. Okada, L.-S. Chang, and M. T. Muller
p53 Dependence of Topoisomerase I Recruitment in Vivo
Cancer Res., August 1, 2000; 60(16): 4538 - 4543.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
Y. Kwon, B. S. Shin, and I. K. Chung
The p53 Tumor Suppressor Stimulates the Catalytic Activity of Human Topoisomerase II{alpha} by Enhancing the Rate of ATP Hydrolysis
J. Biol. Chem., June 16, 2000; 275(24): 18503 - 18510.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. R. Grabowski, K. A. Holmes, M. Aoyama, Y. Ye, L. A. Rybicki, R. M. Bukowski, M. K. Ganapathi, I. D. Hickson, and R. Ganapathi
Altered Drug Interaction and Regulation of Topoisomerase II{beta}: Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide
Mol. Pharmacol., December 1, 1999; 56(6): 1340 - 1345.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. D. Cline and N. Osheroff
Cytosine Arabinoside Lesions Are Position-specific Topoisomerase II Poisons and Stimulate DNA Cleavage Mediated by the Human Type II Enzymes
J. Biol. Chem., October 15, 1999; 274(42): 29740 - 29743.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A.-M. C. Dingemans, M. A. Witlox, R. A. L. M. Stallaert, P. van der Valk, P. E. Postmus, and G. Giaccone
Expression of DNA Topoisomerase II{{alpha}} and Topoisomerase II{beta} Genes Predicts Survival and Response to Chemotherapy in Patients with Small Cell Lung Cancer
Clin. Cancer Res., August 1, 1999; 5(8): 2048 - 2058.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Q. Q. Pu and W. R. Bezwoda
Induction of Alkylator (Melphalan) Resistance in HL60 Cells Is Accompanied by Increased Levels of Topoisomerase II Expression and Function
Mol. Pharmacol., July 1, 1999; 56(1): 147 - 153.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
P. Grue, A. Grässer, M. Sehested, P. B. Jensen, A. Uhse, T. Straub, W. Ness, and F. Boege
Essential Mitotic Functions of DNA Topoisomerase II{alpha} Are Not Adopted by Topoisomerase II{beta} in Human H69 Cells
J. Biol. Chem., December 11, 1998; 273(50): 33660 - 33666.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. R. Daum and G. J. Gorbsky
Casein Kinase II Catalyzes a Mitotic Phosphorylation on Threonine 1342 of Human DNA Topoisomerase II{alpha}, Which Is Recognized by the 3F3/2 Phosphoepitope Antibody
J. Biol. Chem., November 13, 1998; 273(46): 30622 - 30629.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Aoyama, D. R. Grabowski, R. J. Isaacs, K. A. Krivacic, L. A. Rybicki, R. M. Bukowski, M. K. Ganapathi, I. D. Hickson, and R. Ganapathi
Altered Expression and Activity of Topoisomerases During All-Trans Retinoic Acid-Induced Differentiation of HL-60 Cells
Blood, October 15, 1998; 92(8): 2863 - 2870.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Munoz, M. Z. Zdzienicka, J.-M. Blanchard, and J. Piette
Hypersensitivity of Ku-Deficient Cells toward the DNA Topoisomerase II Inhibitor ICRF-193 Suggests a Novel Role for Ku Antigen during the G2 and M Phases of the Cell Cycle
Mol. Cell. Biol., October 1, 1998; 18(10): 5797 - 5808.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Furukawa, T. Uchiumi, M. Nomoto, H. Takano, R. I. Morimoto, S. Naito, M. Kuwano, and K. Kohno
The Role of an Inverted CCAAT Element in Transcriptional Activation of the Human DNA Topoisomerase II{alpha} Gene by Heat Shock
J. Biol. Chem., April 24, 1998; 273(17): 10550 - 10555.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. R. Hammonds, A. Maxwell, and J. R. Jenkins
Use of a Rapid Throughput In Vivo Screen To Investigate Inhibitors of Eukaryotic Topoisomerase II Enzymes
Antimicrob. Agents Chemother., April 1, 1998; 42(4): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Sugimoto, K. Yamada, M. Egashira, Y. Yazaki, H. Hirai, A. Kikuchi, and K. Oshimi
Temporal and Spatial Distribution of DNA Topoisomerase II Alters During Proliferation, Differentiation, and Apoptosis in HL-60 Cells
Blood, February 15, 1998; 91(4): 1407 - 1417.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Redwood, S. L. Davies, N. J. Wells, A. M. Fry, and I. D. Hickson
Casein Kinase II Stabilizes the Activity of Human Topoisomerase II{alpha} in a Phosphorylation-independent Manner
J. Biol. Chem., February 6, 1998; 273(6): 3635 - 3642.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
K. N. Meyer, E. Kjeldsen, T. Straub, B. R. Knudsen, I. D. Hickson, A. Kikuchi, H. Kreipe, and F. Boege
Cell Cycle-coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme Activities
J. Cell Biol., February 24, 1997; 136(4): 775 - 788.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Nakajima, K. Morita, N. Ohi, T. Arai, N. Nozaki, A. Kikuchi, F. Osaka, F. Yamao, and K. Oda
Degradation of Topoisomerase II{alpha} during Adenovirus E1A-induced Apoptosis Is Mediated by the Activation of the Ubiquitin Proteolysis System
J. Biol. Chem., October 4, 1996; 271(40): 24842 - 24849.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. Kimura, N. Nozaki, T. Enomoto, M. Tanaka, and A. Kikuchi
Analysis of M Phase-specific Phosphorylation of DNA Topoisomerase II
J. Biol. Chem., August 30, 1996; 271(35): 21439 - 21445.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R. J. Isaacs, A. L. Harris, and I. D. Hickson
Regulation of the Human Topoisomerase II{alpha} Gene Promoter in Confluence-arrested Cells
J. Biol. Chem., July 12, 1996; 271(28): 16741 - 16747.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Morse-Gaudio and M. S. Risley
Topoisomerase II expression and VM-26 induction of DNA breaks during spermatogenesis in Xenopus laevis
J. Cell Sci., October 1, 1994; 107(10): 2887 - 2898.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
D. J. Clarke, R. T. Johnson, and C. S. Downes
Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks
J. Cell Sci., June 1, 1993; 105(2): 563 - 569.
[Abstract] [PDF]


Home page
J Biol ChemHome page
Y. Kwon, B. S. Shin, and I. K. Chung
The p53 Tumor Suppressor Stimulates the Catalytic Activity of Human Topoisomerase II{alpha} by Enhancing the Rate of ATP Hydrolysis
J. Biol. Chem., June 16, 2000; 275(24): 18503 - 18510.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
H. U. Barthelmes, P. Grue, S. Feineis, T. Straub, and F. Boege
Active DNA Topoisomerase II{alpha} Is a Component of the Salt-stable Centrosome Core
J. Biol. Chem., December 8, 2000; 275(49): 38823 - 38830.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. Tsutsui, K. Tsutsui, K. Sano, A. Kikuchi, and A. Tokunaga
Involvement of DNA Topoisomerase II{beta} in Neuronal Differentiation
J. Biol. Chem., February 23, 2001; 276(8): 5769 - 5778.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Y. Mao, S. D. Desai, C.-Y. Ting, J. Hwang, and L. F. Liu
26 S Proteasome-mediated Degradation of Topoisomerase II Cleavable Complexes
J. Biol. Chem., November 2, 2001; 276(44): 40652 - 40658.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1991 by the American Association of Cancer Research.